Loading...
Loading...
Application UK00801207756 · Registered

| Application Number | UK00801207756 |
| Status | Registered |
| Owner | Neurimmune Holding AG |
| Filed | 2014-02-27 |
| Registered | 2015-05-05 |
| Renewal Due | 2034-02-27 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
Yes. neurimmune Promind antibody therapeutics is currently a registered UK trademark, with renewal due on 2034-02-27. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Chemical products; chemical preparations for industrial purposes; chemical preparations for scientific purposes other than for medical or veterinary use; chemical preparations for photography; biological materials other than for medical or veterinary purposes; biological preparations other than for medical or veterinary use; peptides for chemical products and foodstuffs; polypeptides.
Pharmaceutical preparations; veterinary preparations; preparations for immunotherapeutic purposes; products for the removal of tumors; preparations for neurodegenerative diseases; immunogens; antibodies, epitopes, vaccines; peptides for pharmaceutical purposes; sanitary preparations for medical use; biological preparations for medical use; biocides; diagnostic preparations; towels for hygiene purposes; dietetic foods for medical use; dietetic beverages for medical use; protein antibodies for medical purposes.
Monitoring and inspection for the quality control and analysis of active substances, together with research involving pharmaceutical products, cosmetics or foodstuffs, consultancy and information on monitoring and inspection for the quality control and analysis of active substances, together with research involving pharmaceutical products, cosmetics or foodstuffs; monitoring and inspection for the quality control and analysis of active substances, together with research involving medical treatment and methods; research in the fields of biotechnology and antibodies; information on monitoring and inspection for the quality control and analysis of active substance testing and research in technical and medical treatment; research in the field of sanitary care; monitoring, inspection and research in the field of biology; computer software design, computer programming and computer maintenance; design and development of computer hardware; development of software; consultancy and provision of information relating to quality control of pharmaceutical preparations.
Medical services; medical services in the field of immunity; provision of medical information; medical examinations; preparation and dispensing of medicines; nutritional and dietary consultancy; consultancy and provision of information in the field of sanitary care; veterinary assistance; beauty salon services; care services for animals; hygienic care; consultancy and provision of information relating to the operation, preparation, administration and dosage of pharmaceutical preparations.
This figurative mark is indexed under the following Vienna categories by the UK IPO:
'neurimmune Promind antibody therapeutics' is a registered trademark on the UK IPO register, owned by Neurimmune Holding AG. The application (UK00801207756) was filed on 27 February 2014 and registered on 5 May 2015. The registration is set to expire on 27 February 2034.
This mark is recorded under multiple classes: Class 1 (chemicals for industrial, scientific & agricultural use); Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services).
The trademark is represented by Brand Protect Limited.
UK trademark UK00801207756 for the mark 'neurimmune Promind antibody therapeutics' in Class 1, 5, 42, 44 is recorded on the UK IPO register as owned by Neurimmune Holding AG. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00801207756 for the mark 'neurimmune Promind antibody therapeutics' as registered.
UK trademark UK00801207756 for the mark 'neurimmune Promind antibody therapeutics' is recorded in Class 1 (chemicals for industrial, scientific & agricultural use); Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 1: Chemical products; chemical preparations for industrial purposes; chemical preparations for scientific purposes other than for medical or veterinary use; chemical preparations for photography; biological materials other than for medical or veterinary purposes; biological preparations other than for medical…
UK trademark UK00801207756 for the mark 'neurimmune Promind antibody therapeutics' was filed at the UK IPO on 27 February 2014 and registered on 5 May 2015.
UK trademark UK00801207756 for the mark 'neurimmune Promind antibody therapeutics' is currently recorded as valid until 27 February 2034, at which point it will need to be renewed with the UK IPO to remain in force.
Brand Protect Limited is listed as the attorney / representative of record for UK trademark UK00801207756 for the mark 'neurimmune Promind antibody therapeutics' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.